FDA Panel Backs XFG Strain for 2026-27 COVID Vaccine Update

Advisers to the U.S. Food and Drug Administration (FDA) have backed the XFG strain for the 2026-2027 COVID-19 vaccine update. This decision follows a routine review of vaccine composition to combat evolving variants.